Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Advaxis
3158
Advaxis
Technology
Biotechnology
Health Care
Medical
Diagnostics
Health Diagnostics
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies. $ADXS
Suggest edits
Founded
2002
Raised
$30M
Follow us
Companies in the same industry
Arrogene
Avidity Biosciences
CCG
Cambridge Cancer Genomics
Transgenomic
Nevro
20/20 Gene Systems Inc.
Linkage Biosciences
ID Genomics
23Mofang
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$30,000,000
Post-IPO equity - 2016
Jefferies Group
Guggenheim Securities
Cantor Fitzgerald
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
the home of AI info
Contrasting of Advaxis Inc. (ADXS) and Minerva Neurosciences Inc. (NASDAQ:NERV)
Xconomy
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy
Robotics
Health
$30,000,000
Post-IPO equity
New Jersey Business Magazine
Advaxis Secures $30M Direct Placement Financing
Stock markets
The Motley Fool
Why Advaxis, Inc. Stock Rose 19.6% in May
The Motley Fool
Profit-Taking Clobbers Advaxis, Inc. in April Despite Positive PR
Health
Stock markets
The Motley Fool
Here's Why Advaxis Inc.'s Stock Roared Higher in March
The Motley Fool
Why Advaxis, Inc. Shares Are Soaring 16% Today
Health
Stock markets
The Motley Fool
Why Advaxis Gained 20% in 2015 --
The Motley Fool
Why Advaxis, Inc Shares are Skyrocketing Today --
Health
Stock markets
The Motley Fool
Here's Why Advaxis' Stock Gained 11% in October --
